“…Although a certain number of lankacidin derivatives have been prepared through enzymatic esterification or sophisticated chemical transformations, these approaches are rather limited, as the modification of the parent structure was found to be difficult due to facile cleavage of the C2–C18 bond upon exposure to even mild acidic or basic conditions. ,, A de novo synthesis arguably provides far greater opportunities and flexibility for discovering new bioactive entities . Over the past three decades, the fragile and congested structure has enticed significant interest from several groups to forge the C2–C18 bond with elaborate functional groups at an early stage in their synthetic blueprint. , Only the Kende group accomplished the landmark synthesis of lankacidin C ( 1 ) with an enormous 34 LLS (longest linear steps) (46 total steps) from two chiral building blocks . Alternatively, a flavin-dependent amine oxidoreductase ( Lkc E) was preliminary identified to biosynthetically participate in the unprecedented intramolecular Mannich-type cyclization (Scheme B). , Kinashi and others also uncovered that polyketide synthases from Streptomyces rochei constructed the entire carbon chain first (such as LC-KA05, 6 ) and that subsequent oxidation at C18 revealed a reactive alkenyl N -acyl imine. − Although the detailed enzymatic underpinnings for this extremely rare ring-forming reaction remain to be clarified (such as involving an enolate-iminium pair 7 ), from a synthetic standpoint, a biomimetic approach would drastically decrease the number of steps if the proper precursor and reaction conditions could be defined.…”